NDC 0121-2976

Lacosamide

Lacosamide

Lacosamide is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Pai. The primary component is Lacosamide.

Product ID0121-2976_a95d174d-efee-4ba5-8734-9adaad16be27
NDC0121-2976
Product TypeHuman Prescription Drug
Proprietary NameLacosamide
Generic NameLacosamide
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2022-05-31
Marketing CategoryANDA /
Application NumberANDA209301
Labeler NamePAI
Substance NameLACOSAMIDE
Active Ingredient Strength150 mg/15mL
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0121-2976-95

1 TRAY in 1 CASE (0121-2976-95) > 10 CUP, UNIT-DOSE in 1 TRAY > 15 mL in 1 CUP, UNIT-DOSE (0121-2976-15)
Marketing Start Date2022-11-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lacosamide" or generic name "Lacosamide"

NDCBrand NameGeneric Name
0121-0992LacosamideLacosamide
0121-1984LacosamideLacosamide
0121-2976LacosamideLacosamide
0121-3968LacosamideLacosamide
63850-0055LacosamideLacosamide
63850-0053LacosamideLacosamide
63850-0054LacosamideLacosamide
63850-0056LacosamideLacosamide
65162-912LacosamideLacosamide
0131-1810Vimpatlacosamide
0131-2470Vimpatlacosamide
0131-2477Vimpatlacosamide
0131-2478Vimpatlacosamide
0131-2479Vimpatlacosamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.